Please Wait...

Pathway to Quality Cardiovascular Imaging Trials

Cardiovascular diseases are the leading cause of death in the world and as such, the cause, prevention and treatment of all cardiovascular disease remains a very active field in the research community. Cardiovascular Imaging is a primary therapeutic service area for Bioclinica, offering comprehensive centralized medical imaging services and support for the majority of all cardiovascular imaging (CVI) modalities leveraged to provide critical endpoint assessments in clinical research.

The corner stone to our service is Quality. There are many facets to incorporating imaging into a research protocol and is a road traveled for many years at Bioclinica. Our experience covers imaging modalities across a broad range of cardiovascular and non-cardiovascular therapeutics and devices. We have the physician expertise readily available to provide current clinical knowledge to deploy imaging strategies most appropriate for the study endpoints.

There is much more to imaging in clinical research than collecting scans and analyzing them. It includes many components for a successful outcome of quality data. A thoughtful and comprehensive imaging protocol, training across the study team, and an imaging charter with the appropriate analysis parameters are just some of the critical stops on the road to quality and timely delivery of imaging data.

Our experience covers many of the key cardiovascular disease states that inflict patients today such as heart failure, atherosclerosis, hypertension, valvular disease, cardiomyopathies and vascular disease. Published imaging guidelines and documented standard procedures are applied to trials investigating new treatments for these conditions across all CVI modalities for the consistent collection and processing of data to ensure integrity for your trial. Additionally, many non-cardiovascular diseases such as cancer, rheumatoid arthritis and muscular dystrophy leverage cardiovascular imaging to assess safety in the development of new therapies.

With 30+ years of experience in the conduct of imaging clinical trials, Bioclinica offers in-house expertise as well as a network of academic and research Key Opinion Leaders (KOLs) who readily conduct image review, quality assessment and imaging charter support. Our KOLs are well recognized for their cardiovascular expertise and act as additional resources as you plan your cardiovascular drug programs.

If you'd like to learn more about Bioclinica's Cardiovascular Imaging services, please download our data sheet. If you are attending ACC 2017 in Washington, DC, March 17-19, 2017, we welcome a chance to connect. Email me to pre-arrange a one-to-one meeting.

Category: 

Meet with us!

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Come talk to #Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficac… https://t.co/h0ng6StIbU
Bioclinica (11 hours ago)
Great insights for sponsors conducting #NAFLD #NASH #clinical trials. https://t.co/TG1WwRhVE8 https://t.co/US2Iobjoyd
Bioclinica (Yesterday)
Visit us at @DrugInfoAssn's DIA China to learn how Bioclinica's science & technology expertise can advance the deve… https://t.co/r4822CjVvv
Bioclinica (3 days ago)
Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (6 days ago)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (1 week ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box